Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by geeps2015on Nov 10, 2009 7:09pm
509 Views
Post# 16473127

Just my opinion...

Just my opinion...You are all getting too excited for nothing.  Today, all my small cap. companies went up substantially on thin air, including this one.  The saying goes "When the tide rises, so do the boats".  Tomorrow, the TSX is opened and I think we're going to see a fair pullback on all small caps, barring the ones that have good news releases.  I have a small position in this one, and I will hang on until they release some good news.  This won't happen for at least a year I think.
Bullboard Posts